Article
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
Annals of neurology - 1 Mar 2022
Pal Gian, Mangone Graziella, Hill Emily J, Ouyang Bichun, Liu Yuanqing, Lythe Vanessa, Ehrlich Debra, Saunders-Pullman Rachel, Shanker Vicki, Bressman Susan, Alcalay Roy N, Garcia Priscilla, Marder Karen S, Aasly Jan, Mouradian M Maral, Link Samantha, Rosenbaum Marc, Anderson Sharlet, Bernard Bryan, Wilson Robert, Stebbins Glenn, Nichols William C, Welter Marie-Laure, Sani Sepehr, Afshari Mitra, Verhagen Leo, de Bie Rob M A, Foltynie Tom, Hall Deborah, Corvol Jean-Christophe, Goetz Christopher G
Abstract excerpt
OBJECTIVE: This study was undertaken to compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and noncarriers with and without subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson disease. METHODS: Clinical and genetic data from 12 datasets were examined. Global cognition was assessed using the Mattis Dementia Rating Scale (MDRS). Subjects were examined for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
